Thrive Wealth Management
PFE icon

Thrive Wealth Management’s Pfizer PFE Stock Holding History

Thrive Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$824K Buy
28,892
+237
+0.8% +$6.3K 0.1% 95
2026
Q2 		$690K Sell
28,655
-522
-2% -$13.7K 0.09% 106
2026
Q1 		$819K Buy
29,177
+322
+1% +$8.57K 0.12% 88
2025
Q4 		$718K Sell
28,855
-11,792
-29% -$297K 0.11% 100
2025
Q3 		$1.04M Sell
40,647
-826
-2% -$20.4K 0.16% 72
2025
Q2 		$1.01M Sell
41,473
-3,819
-8% -$89.1K 0.16% 73
2025
Q1 		$1.15M Buy
45,292
+5,021
+12% +$131K 0.22% 50
2024
Q4 		$1.07M Sell
40,271
-14,354
-26% -$389K 0.19% 60
2024
Q3 		$1.58M Sell
54,625
-313
-0.6% -$9.13K 0.29% 42
2024
Q2 		$1.54M Buy
54,938
+14,349
+35% +$395K 0.3% 38
2024
Q1 		$1.13M Sell
40,589
-345
-0.8% -$9.6K 0.23% 53
2023
Q4 		$1.18M Sell
40,934
-7,607
-16% -$230K 0.26% 49
2023
Q3 		$1.61M Buy
48,541
+3,716
+8% +$131K 0.43% 26
2023
Q2 		$1.64M Sell
44,825
-1,090
-2% -$42.4K 0.43% 26
2023
Q1 		$1.87M Buy
45,915
+1,993
+5% +$86.1K 0.48% 26
2022
Q4 		$2.25M Buy
43,922
+2,458
+6% +$118K 0.64% 22
2022
Q3 		$1.81M Buy
41,464
+652
+2% +$31.7K 0.64% 22
2022
Q2 		$2.14M Buy
40,812
+206
+0.5% +$10.5K 0.75% 22
2022
Q1 		$2.1M Sell
40,606
-1,071
-3% -$55.6K 0.62% 22
2021
Q4 		$2.46M Buy
+41,677
New +$2.06M 0.84% 17

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Thrive Wealth Management's PFE Position: Q3 2026 in Review

Thrive Wealth Management increased its Pfizer (PFE) stake by 0.83% in Q3 2026, buying an estimated $6.3K and bringing the position to 28,892 shares worth $824K. The position accounts for 0.1% of the portfolio, ranked #95.

Thrive Wealth Management first reported a position in PFE in Q4 2021 and has held it in 20 quarters since. The position peaked at $2.46M in Q4 2021. 781 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Thrive Wealth Management held 28,892 shares of Pfizer worth $824K as of Q3 2026.
  • Thrive Wealth Management bought 237 Pfizer shares in Q3 2026, an estimated $6.3K.
  • Pfizer made up 0.1% of Thrive Wealth Management's portfolio in Q3 2026, its #95 holding.
  • Thrive Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 20 quarters since.
  • Thrive Wealth Management's Pfizer position peaked at $2.46M in Q4 2021.
  • 781 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Thrive Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.